Диссертация (1139655), страница 55
Текст из файла (страница 55)
Sharma, D. S. Itum,L. Moss, C. Li // World J. Surg. – 2014. – Vol. 38 (6). – P. 1268-1273.258.Singh Ospina, N. M. Outcomes of Parathyroidectomy in Patients with PrimaryHyperparathyroidism: A Systematic Review and Meta-analysis //.N. M. Singh Ospina,R. Rodriguez-Gutierrez, S.
Maraka, A. E. Espinosa de Ycaza, S. Jasim // World J Surg.– 2016. – Apr 19. – P. 1–19.259.Siprova, H. Z. Primary hyperparathyroidism with a focus on management of thenormocalcemic form: to treat or not to treat / H. Z. Siprova, M. Frysak // EndocrinePractice. – Vol.
22. – P. 3.260.Soma, R. Changes in serum intact parathyroid hormone levels and ultrasonicfindings after percutaneous ethanol injection therapy in a patient with primaryhyperparathyroidism / R. Soma, Y. Takayama, T. Mimo // World J. Surg. – 1995. – Vol.71 (1). – P. 53-64.261.Sriphrapradang, C. Fine–needle aspiration cytology of parathyroid carcinomamimic hurtle cell thyroid neoplasm / C.
Sriphrapradang, P. Sornmayura, N.Chanplakorn, O. Trachoo et al. // Case Rep. Endocrinol. – 2014. – Vol. 6. – P. 8086.339262.Stein, E. M. Vitamin D deficiency influences histomorphometric features ofbone in primary hyperparathyroidism / E. M. Stein, D. W. Dempster, J. Udesky, H.Zhou et al. // Bone. – 2011. – Vol.
48 (3). – P. 557-561.263.Tachibana, S. Surgically proven normocalcemic primary hyperparathyroidism:speculation of the possible role of estrogen in the etiology of this disease inpremenopausal women / S. Tachibana, T. Yokoi, S. Sato, T. Yanase // InternalMedicine. – 2013. – Vol. 52 (7). – P. 781-785.264.Teksoz, S. Minimal invasive parathyroidectomy with local anesthesia for well–localized primary hyperparathyroidism: "Cerrahpasa experience" / S. Teksoz, Y. Bukey,M. Ozcan, A.
E. Arikan et al. // Updates Surg. – 2013. – Vol. 65 (3). – P. 217-23.265.Thomas, D. C. Roman SA, Sosa JA. Parathyroidectomy in the elderly: analysisof 7313 patients / D. C. Thomas, S. A. Roman, J. A. Sosa // J. Surg. Res. – 2011. – Vol.170 (2). – P. 240-246.266.Tochio, M. A. case report of – 20 lung radiofrequency ablation sessions for 50lung metastases from parathyroid carcinoma causing hyperparathyroidism / M. A.Tochio, H.
Takaki, K. Yamakado, J. Uraki et al. // Cardiovasc. Intervent. Radiol. –2010. – Vol. 33 (3). – P. 657-659.267.Touvier, M. Interpretation of plasma PTH concentrations according to – 25(OH)D status, gender, age, weight status, and calcium intake: importance of the referencevalues / M. Touvier, M. Deschasaux, M. Montourcy, A. Sutton // J. Clin. Endocrinol.Metab. – 2014.
– Vol. 99 (4). – P. 1196-1203.268.Triggiani, V. Parathyroid hormone determination in ultrasound–guided fineneedle aspirates allows the differentiation between thyroid and parathyroid lesions: ourexperience and review of the literature / V. Triggiani, F. Resta, V.A. Giagulli, M. Iovinoet al. // Endocr.
Metab. Immune Disord. Drug. Targets. – 2013. – Vol. 13 (4). – P. 351358.269.Tucci, J. R. Vitamin D therapy in patients with primary hyperparathyroidismand hypovitaminosis D / J. R. Tucci // Eur. J. Endocrinol. – 2009. – Vol. 161 (1). – P.189-193.340270.Van Udelsman, B. Surgery in primary hyperparathyroidism: extensive personalexperience / B. Van Udelsman, R. Udelsman // J.
Clin. Densitom. – 2013. – Vol. 16 (1).– P. 54-59.271.Velayoudom–Cephise, F. L. Primary hyperparathyroidism and vitamin Ddeficiency / F. L. Velayoudom–Cephise, J. L. Wemeau // Ann. Endocrinol. (Paris). –2015. – Vol. 76 (2). – P. 153-162.272.Wade,T.J.Surgicalmanagementofnormocalcemicprimaryhyperparathyroidism / T. J. Wade, T. W. Yen, A. L. Amin, T. S. Wang // World J. Surg.– 2012.
– Vol. 36 (4). – P. 761-766.273.Walker, M. D. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical,Biochemical, and Densitometric Presentation / M. D. Walker, E. Cong, J. A. Lee, A.Kepley et al. // The Journal of Clinical Endocrinology & Metabolism. – 2015. – Vol.100 (9). – P. 20-22.274.Williams, B.
A. Surgical management of primary hyperparathyroidism inCanada / B. A. Williams, J. R. Trites, S. M. Taylor, M. J. Bullock // J. Otolaryngol.Head. Neck. Surg. – 2014. – Vol. 1. – P. 43-44.275.Xu, S. Y. Percutaneous sonographically–guided radiofrequency ablation in themanagement of parathyroid adenoma / S. Y. Xu, Y. Wang, Q. Xie, H.
Y. Wu //Singapore Med. J. – 2013. – Vol. 54 (7). – P. 137-140.276.Yacobi–Bach, M. Letter to the editor: thiazides are not inducers of PTHsecretion: a comment on normocalcemic hyperparathyroidism / M. Yacobi–Bach, M.Serebro, Y. Greenman, K. Tordjman // The Journal of Clinical Endocrinology &Metabolism. – 2014. – Vol. 100 (2). – P. 40-65.277.Yeh, M. W. Incidence and prevalence of primary hyperparathyroidism in aracially mixed population / M. W. Yeh // J. Clin.
Endocrinol. Metab. – 2013. – Vol. 98(3). – P. 1122-1129.278.Yu, M. A. Safety and efficiency of microwave ablation for recurrent andpersistent secondary hyperparathyroidism after parathyroidectomy: A retrospective pilotstudy / M.
A. Yu, L. Yao, L. Zhang, L. Peng et al. // Int. J. Hyperthermia. – 2016 – Vol.32 (2). – P. 180-186.341279.Zhao, J. Efficacy of ablation therapy for secondary hyperparathyroidism byultrasound guided percutaneous thermoablation / J. Zhao, L. Qian, Y. Zu , Y. Wei et al.// Ultrasound. Med. Biol. – 2016. – Vol. 42 (5). – P. 1058-1065.280.Zhao, L. The changing clinical patterns of primary hyperparathyroidism inChinese patients: Data from – 2000 to – 2010. – in a single clinical center / L. Zhao, J.M.
Liu, X. Y. He et al. // J. Clin. Endocrinol. Metab. – 2013. – Vol. 98. – P. 721-728..